Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GoPro Inc (Class A) | Nicholas Woodman | Director, CEO, Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Jul 2026 | 19,280,205 | 19,280,205 | - | - | Warrants (right to buy) | |
| TruBridge Inc | Damien Leonard | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 2,130,000 | 0 (0%) | 14% | 26.3 | 55,912,500 | Common stock, par value $0.001 per share ("Common Stock") |
| TruBridge Inc | Andris Upitis | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 1,114,178 | 0 (0%) | 7% | 26.3 | 29,247,173 | Common Stock |
| TruBridge Inc | Damien Leonard | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 850,000 | 0 (0%) | 5% | 26.3 | 22,312,500 | Common Stock |
| Gloo Holdings Inc Ordinary | John Douglas Furst | Director | 09 Jul 2026 | 732,856 | 732,856 | - | - | Class A Common Stock | ||
| Gloo Holdings Inc Ordinary | John Douglas Furst | Director | 09 Jul 2026 | 732,856 | 0 | - | - | Class B Common Stock | ||
| Gloo Holdings Inc Ordinary | John Douglas Furst | Director | 09 Jul 2026 | 544,444 | 0 | - | - | Class B Common Stock | ||
| Gloo Holdings Inc Ordinary | John Douglas Furst | Director | 09 Jul 2026 | 544,444 | 544,444 | - | - | Class A Common Stock | ||
| Cue Biopharma Inc | Shao-Lee Lin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 327,537 | 655,074 (2%) | 1% | 0 | Common Stock | |
| Cue Biopharma Inc | Shao-Lee Lin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 327,537 | 327,537 | - | - | Common Stock | |
| Traws Pharma Inc | Iain D. Dukes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 274,000 | 274,000 | - | - | Stock Option (right to buy) | |
| Bitfarms Ltd | Ganesh Aiyer | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 259,516 | 259,516 | - | - | Restricted Stock Units | |
| PSQ Holdings Inc (Class A) | Blake Masters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 258,929 | 442,827 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| Petco Health and Wellness Co Inc (Class A) | Holly May | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 2.54 per share. | 09 Jul 2026 | 200,000 | 1,327,867 | - | 2.5 | 508,000 | Class A Common Stock |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 182,366 | 182,366 | - | - | Restricted Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 136,774 | 136,774 | - | - | Performance Stock Units | |
| DocuSign Inc | Allan Thygesen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 136,774 | 136,774 | - | - | Performance Stock Units | |
| PSQ Holdings Inc (Class A) | Caitlin Long | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 125,000 | 125,000 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| PSQ Holdings Inc (Class A) | Davis Pilot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 125,000 | 272,514 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| PSQ Holdings Inc (Class A) | James Rinn | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 125,000 | 254,864 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| PSQ Holdings Inc (Class A) | Donald J. Trump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 125,000 | 822,403 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| PSQ Holdings Inc (Class A) | Willie Langston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 125,000 | 521,205 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| TruBridge Inc | Christopher L. Fowler | Director, President and CEO | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 120,486 | 0 (0%) | 0% | 26.3 | 3,162,758 | Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 188.56 per share. | 09 Jul 2026 | 113,134 | 17,316,525 (22%) | 0% | 188.6 | 21,332,389 | Common Stock |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.00 per share. | 09 Jul 2026 | 112,422 | 139,805 (0%) | 0% | 29 | 3,260,238 | Common Stock |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 09 Jul 2026 | 112,422 | 8,383 (0%) | 0% | 90 | 10,117,980 | Common Stock |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 112,422 | 0 | - | - | Stock Option (Right to Buy) | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 09 Jul 2026 | 107,500 | 212,549 (0%) | 0% | 0 | Class A Common Stock | ||
| Workday (Class A) | David A. Duffield | Ten Percent Owner | 09 Jul 2026 | 107,500 | 36,453,834 | - | - | Class B Common Stock | ||
| Personalis Inc | Christopher Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 09 Jul 2026 | 100,000 | 235,986 (0%) | 0% | 15.1 | 1,508,000 | Common Stock |
| Personalis Inc | Christopher Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share. | 09 Jul 2026 | 100,000 | 335,986 (1%) | 0% | 1.6 | 161,000 | Common Stock |
| Bitfarms Ltd | Ganesh Aiyer | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 100,000 | 100,000 | - | - | Stock Options (Right to Buy) | |
| Concrete Pumping Holdings Inc (Class A) | M. Brent Stevens | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 09 Jul 2026 | 97,700 | 497,155 (0%) | 0% | 10.8 | 1,058,179 | Common Stock |
| Traws Pharma Inc | Charles David Pauza | Chief Science Officer Virology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 97,000 | 97,000 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc | Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 93,000 | 93,000 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc | Charles Parker | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 89,200 | 89,200 | - | - | Restricted Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 89,200 | 89,200 | - | - | Restricted Stock Units | |
| Edwards Lifesciences | Theodora Mistras | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 87,595 | 87,595 (0%) | 0% | 0 | Common Stock | |
| Traws Pharma Inc | Robert R Redfield | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 84,000 | 84,000 | - | - | Stock Option (right to buy) | |
| Village Farms Intl Inc | Kathleen M. Mahoney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | Kathleen M. Mahoney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 192,567 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | John R. McLernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 231,399 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | John R. McLernon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | Christopher Woodward | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | Christopher Woodward | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 176,677 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | John Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | John Henry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 268,899 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | David Holewinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | David Holewinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 305,607 (0%) | 0% | 0 | Common Shares | |
| Village Farms Intl Inc | Carolyn Hauger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 0 | - | - | Restricted Stock | |
| Village Farms Intl Inc | Carolyn Hauger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 75,757 | 170,567 (0%) | 0% | 0 | Common Shares | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 74,333 | 74,333 | - | - | Restricted Stock Units | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 09 Jul 2026 | 68,289 | 2,774,893 | - | 20.0 | 1,367,146 | Class A ordinary shares, par value $0.0001 per share |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 09 Jul 2026 | 67,971 | 1,306,108 (1%) | 0% | 7.0 | 473,330 | Common Stock |
| Personalis Inc | Christopher Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 66,667 | 133,333 | - | - | Stock Option (right to buy) | |
| Pure Storage Inc (Class A) | Charles H. Giancarlo | Director, CEO | Sale of securities on an exchange or to another person at price $ 80.05 per share. | 09 Jul 2026 | 65,800 | 1,749,597 (0%) | 0% | 80.1 | 5,267,290 | Class A Common Stock |
| Edwards Lifesciences | Theodora Mistras | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 61,800 | 61,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Pliant Therapeutics Inc | Robert Iannone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Flavia Borellini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| TruBridge Inc | Michael Daughton | Chief Business Officer | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 59,315 | 0 (0%) | 0% | 26.3 | 1,557,019 | Common Stock |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 54,589 | 54,589 | - | - | Common Stock | |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 54,589 | 109,178 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 187.31 per share. | 09 Jul 2026 | 52,351 | 17,429,659 (22%) | 0% | 187.3 | 9,805,981 | Common Stock |
| LegalZoom.com Inc | Noel Watson | Chief Operating Officer & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.21 per share. | 09 Jul 2026 | 51,545 | 1,990,302 | - | 7.2 | 371,639 | Common Stock |
| LegalZoom.com Inc | Nicole Miller | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.21 per share. | 09 Jul 2026 | 51,545 | 1,067,677 | - | 7.2 | 371,639 | Common Stock |
| TruBridge Inc | Glenn P. Tobin | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 50,687 | 0 (0%) | 0% | 26.3 | 1,330,534 | Common Stock |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 49,555 | 49,555 | - | - | Restricted Stock Units | |
| Pure Storage Inc (Class A) | Charles H. Giancarlo | Director, CEO | Sale of securities on an exchange or to another person at price $ 80.21 per share. | 09 Jul 2026 | 48,709 | 1,700,888 (0%) | 0% | 80.2 | 3,906,949 | Class A Common Stock |
| Arcus Biosciences Inc | Juan Carlos Jaen | President | Sale of securities on an exchange or to another person at price $ 30.05 per share. | 09 Jul 2026 | 48,502 | 842,307 (1%) | 0% | 30.1 | 1,457,631 | Common Stock |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 44,600 | 44,600 | - | - | Performance Stock Units | |
| DocuSign Inc | Blake Jeffrey Grayson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 44,600 | 44,600 | - | - | Performance Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 44,600 | 44,600 | - | - | Performance Stock Units | |
| DocuSign Inc | Paula Hansen | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 44,600 | 44,600 | - | - | Performance Stock Units | |
| 4D Molecular Therapeutics Inc | David Kirn | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.87 per share. | 09 Jul 2026 | 42,608 | 899,877 | - | 12.9 | 548,177 | Common Stock |
| Cue Biopharma Inc | Michael Meluzio | VP, Prin. Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 40,942 | 40,942 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Michael Meluzio | VP, Prin. Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 40,942 | 40,942 | - | - | Common Stock | |
| TruBridge Inc | Vinay Bassi | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 39,992 | 0 (0%) | 0% | 26.3 | 1,049,790 | Common Stock |
| AMBAC Fin Grp Inc | Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 39,380 | 480,832 | - | - | Restricted Stock Units | |
| AMBAC Fin Grp Inc | Claude L. LeBlanc | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 39,380 | 1,087,011 (2%) | 0% | - | Common Stock | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 137.19 per share. | 09 Jul 2026 | 39,133 | 125,859 (0%) | 0% | 137.2 | 5,368,778 | Class A Common Stock |
| TruBridge Inc | Regina M. Benjamin | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 38,687 | 0 (0%) | 0% | 26.3 | 1,015,534 | Common Stock |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 37,166 | 37,166 | - | - | Performance Stock Units | |
| DocuSign Inc | Robert Chatwani | President General Mgr, Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 37,166 | 37,166 | - | - | Performance Stock Units | |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Sale of securities on an exchange or to another person at price $ 84.00 per share. | 09 Jul 2026 | 36,167 | 120,805 (0%) | 0% | 84 | 3,038,028 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 09 Jul 2026 | 33,936 | 2,843,182 | - | 20.0 | 679,059 | Class A ordinary shares, par value $0.0001 per share |
| Personalis Inc | Christopher Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 33,333 | 0 | - | - | Stock Option (right to buy) | |
| TruBridge Inc | Christopher T. Hjelm | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 31,591 | 0 (0%) | 0% | 26.3 | 829,264 | Common Stock |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.77 per share. | 09 Jul 2026 | 31,249 | 31,249 | - | 21.8 | 680,291 | Common Stock |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 31,249 | 68,751 | - | - | Stock Option (Right to Buy) | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 136.41 per share. | 09 Jul 2026 | 27,858 | 164,992 (0%) | 0% | 136.4 | 3,800,143 | Class A Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 188.56 per share. | 09 Jul 2026 | 25,943 | 5,171,259 (6%) | 0% | 188.6 | 4,891,776 | Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 188.56 per share. | 09 Jul 2026 | 25,943 | 5,171,259 (6%) | 0% | 188.6 | 4,891,776 | Common Stock |
| Trade Desk Inc (Class A) | Penry W. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 25,505 | 25,505 | - | - | Stock Option (Right to Buy) | |
| Plum Acq Corp IV (Class A) | Aidin Aghamiri | Director | 09 Jul 2026 | 25,000 | 25,000 | - | - | Class A ordinary shares | ||
| Plum Acq Corp IV (Class A) | Aidin Aghamiri | Director | 09 Jul 2026 | 25,000 | 0 | - | - | Class B ordinary shares | ||
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 09 Jul 2026 | 24,880 | 493,557 (0%) | 0% | 7.0 | 173,257 | Common Stock |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 24,777 | 24,777 | - | - | Performance Stock Units | |
| DocuSign Inc | James P. Shaughnessy | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 24,777 | 24,777 | - | - | Performance Stock Units | |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 22,217 | 52,684 (0%) | 0% | 0 | Class A Common Stock | |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 22,217 | 199,956 | - | - | Restricted Stock Units | |
| Cue Biopharma Inc | Daniel A. Camardo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 21,800 | 21,800 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Pamela D. Garzone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 21,800 | 21,800 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Pasha Sarraf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 21,800 | 32,595 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Viola Mong Meehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 21,800 | 21,800 (0%) | 0% | 0 | Common Stock | |
| AMBAC Fin Grp Inc | Claude L. LeBlanc | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.08 per share. | 09 Jul 2026 | 21,777 | 1,065,234 (2%) | 0% | 6.1 | 132,404 | Common Stock |
| TruBridge Inc | Mark V. Anquillare | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 21,554 | 0 (0%) | 0% | 26.3 | 565,793 | Common Stock |
| Privia Health Group Inc | David Mountcastle | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.67 per share. | 09 Jul 2026 | 21,275 | 164,853 | - | 27.7 | 588,679 | Common Stock, par value $0.01 per share |
| Trade Desk Inc (Class A) | Penry W. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 20,893 | 20,893 | - | - | Stock Option (Right to Buy) | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 20,751 | 166,606 (0%) | 0% | 0 | Class A Common Stock | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 20,751 | 145,262 | - | - | Restricted Stock Units | |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 138.34 per share. | 09 Jul 2026 | 20,710 | 105,149 (0%) | 0% | 138.3 | 2,865,048 | Class A Common Stock |
| Alector Inc | Grace Wong-Sarad | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 20,000 | 115,461 (0%) | 0% | 0 | Common Stock | |
| GBank Fin Holdings Inc | Jeffrey K Newgard | President/CEO (GBank) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 20,000 | 20,000 | - | 0 | Common Stock | |
| Datadog Inc (Class A) | Amit Agarwal | Director | 09 Jul 2026 | 20,000 | 21,640 (0%) | 0% | - | Class A Common Stock | ||
| Datadog Inc (Class A) | Amit Agarwal | Director | 09 Jul 2026 | 20,000 | 290,059 | - | - | Class B Common Stock | ||
| Arcus Biosciences Inc | Juan Carlos Jaen | President | Sale of securities on an exchange or to another person at price $ 28.61 per share. | 09 Jul 2026 | 19,799 | 822,508 (1%) | 0% | 28.6 | 566,410 | Common Stock |
| BlackBerry Ltd | Tim Foote | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 19,089 | 81,770 (0%) | 0% | - | Common Shares | |
| BlackBerry Ltd | Tim Foote | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 19,089 | 209,968 | - | - | Restricted Share Units | |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.45 per share. | 09 Jul 2026 | 19,000 | 27,383 (0%) | 0% | 8.5 | 160,550 | Common Stock |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 19,000 | 0 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 17,167 | 0 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Jennifer E. Cook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.75 per share. | 09 Jul 2026 | 17,167 | 156,972 (0%) | 0% | 16.7 | 287,547 | Common Stock |
| BridgeBio Pharma Inc | Andrea John Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 17,167 | 17,167 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Andrea John Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.75 per share. | 09 Jul 2026 | 17,167 | 39,746 (0%) | 0% | 16.7 | 287,547 | Common Stock |
| BridgeBio Pharma Inc | Andrea John Ellis | Director | Sale of securities on an exchange or to another person at price $ 84.00 per share. | 09 Jul 2026 | 17,167 | 22,579 (0%) | 0% | 84 | 1,442,028 | Common Stock |
| TruBridge Inc | David B. Harse | General Manager Patient Care | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 16,888 | 0 (0%) | 0% | 26.3 | 443,310 | Common Stock |
| Amphastar Pharma Inc | Anthony T. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 16,646 | 16,646 | - | - | Stock Option (right to buy) | |
| TruBridge Inc | Christopher L. Fowler | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2026 | 16,286 | 120,486 (0%) | 0% | 0 | Common Stock | |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Sale of securities on an exchange or to another person at price $ 101.24 per share. | 09 Jul 2026 | 15,329 | 5,566 | - | 101.2 | 1,551,908 | Common Stock |
| 4D Molecular Therapeutics Inc | David Kirn | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 09 Jul 2026 | 15,283 | 884,594 | - | 12.0 | 183,560 | Common Stock |
| Village Farms Intl Inc | John R. McLernon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.99 per share. | 09 Jul 2026 | 15,151 | 216,248 (0%) | 0% | 2.0 | 30,150 | Common Shares |
| Village Farms Intl Inc | Christopher Woodward | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.99 per share. | 09 Jul 2026 | 15,151 | 161,526 (0%) | 0% | 2.0 | 30,150 | Common Shares |
| Amylyx Pharma Inc | Gina M. Mazzariello | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 17.61 per share. | 09 Jul 2026 | 15,000 | 179,090 | - | 17.6 | 264,122 | Common Stock |
| Amylyx Pharma Inc | Gina M. Mazzariello | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 18.32 per share. | 09 Jul 2026 | 15,000 | 194,090 | - | 18.3 | 274,746 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 135.48 per share. | 09 Jul 2026 | 14,299 | 192,850 (0%) | 0% | 135.5 | 1,937,261 | Class A Common Stock |
| Traws Pharma Inc | Jack E. Stover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 14,150 | 14,150 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc | John H. Leaman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 14,150 | 14,150 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc | Mary Teresa Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 14,150 | 14,150 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 14,150 | 14,150 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc | Werner Cautreels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 14,150 | 14,150 | - | - | Stock Option (right to buy) | |
| Calumet Specialty Products Partners L.P. - Unit | Stephen P. Mawer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 13,780 | 317,090 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Stephen P. Mawer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 13,780 | 0 | - | - | Restricted Stock Unit | |
| AMBAC Fin Grp Inc | David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 13,206 | 124,978 | - | - | Restricted Stock Units | |
| AMBAC Fin Grp Inc | David Trick | Exec VP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 13,206 | 273,837 (0%) | 0% | - | Common Stock | |
| Pure Storage Inc (Class A) | Charles H. Giancarlo | Director, CEO | Sale of securities on an exchange or to another person at price $ 81.51 per share. | 09 Jul 2026 | 12,991 | 1,687,897 (0%) | 0% | 81.5 | 1,058,896 | Class A Common Stock |
| Abeona Therapeutics Inc | Madhav Vasanthavada | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 09 Jul 2026 | 12,606 | 290,623 (0%) | 0% | 7.0 | 87,784 | Common Stock |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 12,500 | 575,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 09 Jul 2026 | 12,500 | 12,500 | - | 2.8 | 35,000 | Class A Common Stock |
| Zoom Video Comm Inc (Class A) | Kimberly J. McGarry | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 12,486 | 12,832 (0%) | 0% | 0 | Class A Common Stock | |
| Zoom Video Comm Inc (Class A) | Kimberly J. McGarry | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 12,486 | 37,458 | - | - | Restricted Stock Units | |
| TruBridge Inc | Kevin Plessner | General Counsel | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 12,460 | 0 (0%) | 0% | 26.3 | 327,075 | Common Stock |
| Edwards Lifesciences | Theodora Mistras | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 12,325 | 99,920 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Theodora Mistras | CVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 12,325 | 12,325 | - | - | Performance Rights | |
| Abeona Therapeutics Inc | Brendan M. O'Malley | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 09 Jul 2026 | 12,050 | 427,953 (0%) | 0% | 7.0 | 83,913 | Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 187.31 per share. | 09 Jul 2026 | 12,005 | 5,197,202 (6%) | 0% | 187.3 | 2,248,683 | Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 187.31 per share. | 09 Jul 2026 | 12,005 | 5,197,202 (6%) | 0% | 187.3 | 2,248,683 | Common Stock |
| AMBAC Fin Grp Inc | R. Sharon Smith | Exec VP & Group COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 11,779 | 160,961 (0%) | 0% | - | Common Stock | |
| AMBAC Fin Grp Inc | R. Sharon Smith | Exec VP & Group COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 11,779 | 132,093 | - | - | Restricted Stock Units | |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 94.97 per share. | 09 Jul 2026 | 11,021 | 108,397 (0%) | 0% | 95.0 | 1,046,637 | Common Stock |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 11,021 | 2,050 | - | - | Employee Stock Option (Right to Buy) | |
| Phillips 66 | Kevin J. Mitchell | Exec. VP and CFO | Sale of securities on an exchange or to another person at price $ 190.03 per share. | 09 Jul 2026 | 11,021 | 97,376 (0%) | 0% | 190.0 | 2,094,285 | Common Stock |
| BlackBerry Ltd | Philip S. Kurtz | CLO & Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 10,908 | 131,572 (0%) | 0% | - | Common Shares | |
| BlackBerry Ltd | Philip S. Kurtz | CLO & Corp. Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 10,908 | 119,982 | - | - | Restricted Share Units | |
| Chewy Inc (Class A) | James L. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,665 | 10,665 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Martin H. Nesbitt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,665 | 10,665 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Deborah G. Ellinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,665 | 10,665 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | James A. Star | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,665 | 10,665 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Kristine Dickson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,665 | 10,665 (0%) | 0% | 0 | Class A Common Stock | |
| Chewy Inc (Class A) | Nat Goldhaber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,665 | 10,665 (0%) | 0% | 0 | Class A Common Stock | |
| Hercules Cap Inc | Scott Bluestein | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 10,652 | 2,475,593 (2%) | 0% | 15.7 | 167,130 | Common Stock |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.40 per share. | 09 Jul 2026 | 10,559 | 156,047 (0%) | 0% | 87.4 | 922,857 | Class A Common Stock |
| TruBridge Inc | Vinay Bassi | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2026 | 10,507 | 39,992 (0%) | 0% | 0 | Common Stock | |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Sale of securities on an exchange or to another person at price $ 100.22 per share. | 09 Jul 2026 | 10,354 | 20,895 | - | 100.2 | 1,037,678 | Common Stock |
| Sonoma Pharma Inc | Amy M. Trombly | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 52,185 | - | - | Restricted Stock Units | |
| Sonoma Pharma Inc | John G. Mclaughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 30,001 | - | - | Stock option (right to buy) | |
| Sonoma Pharma Inc | Jerome J. Dvonch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 44,391 | - | - | Restricted Stock Units | |
| Sonoma Pharma Inc | Philippe Weigerstorfer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 30,001 | - | - | Stock option (right to buy) | |
| Sonoma Pharma Inc | Vanessa Jacoby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 20,000 | - | - | Stock option (right to buy) | |
| UroGen Pharma Ltd | Mark P. Schoenberg | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 09 Jul 2026 | 10,000 | 119,763 (0%) | 0% | 40 | 400,000 | Ordinary Shares |
| Glaukos Corp | Alex R. Thurman | SVP & CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.68 per share. | 09 Jul 2026 | 10,000 | 53,681 (0%) | 0% | 38.7 | 386,800 | Common Stock |
| Glaukos Corp | Alex R. Thurman | SVP & CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Glaukos Corp | Alex R. Thurman | SVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 09 Jul 2026 | 10,000 | 43,681 (0%) | 0% | 155 | 1,550,000 | Common Stock |
| Neurocrine Biosciences Inc | Darin M. Lippoldt | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 179.60 per share. | 09 Jul 2026 | 10,000 | 54,729 (0%) | 0% | 179.6 | 1,796,014 | Common Stock |
| Neurocrine Biosciences Inc | Darin M. Lippoldt | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.49 per share. | 09 Jul 2026 | 10,000 | 64,729 (0%) | 0% | 81.5 | 814,900 | Common Stock |
| Neurocrine Biosciences Inc | Darin M. Lippoldt | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 4,965 | - | - | Non-Qualified Stock Option | |
| PTC Therapeutics Inc | Mary Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 09 Jul 2026 | 10,000 | 21,813 (0%) | 0% | 90 | 900,000 | Common Stock |
| PTC Therapeutics Inc | Mary Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.95 per share. | 09 Jul 2026 | 10,000 | 31,813 (0%) | 0% | 43.0 | 429,500 | Common Stock |
| Hercules Cap Inc | Scott Bluestein | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 9,741 | 2,486,245 (2%) | 0% | 15.7 | 152,836 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 09 Jul 2026 | 9,500 | 50,013 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 9,500 | 30,218 | - | - | Stock Option | |
| TruBridge Inc | Michael Daughton | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2026 | 8,749 | 59,315 (0%) | 0% | 0 | Common Stock | |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.40 per share. | 09 Jul 2026 | 8,743 | 43,941 (0%) | 0% | 87.4 | 764,138 | Class A Common Stock |
| Pure Storage Inc (Class A) | Susan J.S. Taylor | Director | Sale of securities on an exchange or to another person at price $ 81.74 per share. | 09 Jul 2026 | 8,543 | 94,608 (0%) | 0% | 81.7 | 698,305 | Class A Common Stock |
| Pure Storage Inc (Class A) | Charles H. Giancarlo | Director, CEO | Sale of securities on an exchange or to another person at price $ 82.16 per share. | 09 Jul 2026 | 8,300 | 1,679,597 (0%) | 0% | 82.2 | 681,928 | Class A Common Stock |
| BlackBerry Ltd | Tim Foote | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.92 per share. | 09 Jul 2026 | 8,235 | 73,535 (0%) | 0% | 10.9 | 89,926 | Common Shares |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.78 per share. | 09 Jul 2026 | 8,189 | 35,752 (0%) | 0% | 90.8 | 743,425 | Class A Common Stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 267.85 per share. | 09 Jul 2026 | 8,027 | 7,340 (0%) | 0% | 267.8 | 2,150,011 | Class A Common Stock |
| Amphastar Pharma Inc | Anthony T. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 7,886 | 7,886 (0%) | 0% | 0 | Common Stock | |
| TruBridge Inc | Merideth Wilson | Financial Health GM | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 7,734 | 0 (0%) | 0% | 26.3 | 203,018 | Common Stock |
| BlackBerry Ltd | Jennifer Armstrong-Owen | Sr VP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,636 | 109,387 (0%) | 0% | - | Common Shares | |
| BlackBerry Ltd | Jennifer Armstrong-Owen | Sr VP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,636 | 83,987 | - | - | Restricted Share Units | |
| Sonoma Pharma Inc | Poggetto John Dal | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 7,500 | 32,750 | - | - | Restricted Stock Units | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 125.43 per share. | 09 Jul 2026 | 7,489 | 5,011 | - | 125.4 | 939,318 | Class A Common Stock |
| Wolverine World Wide Inc | Jack Boyle | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,459 | 7,459 (0%) | 0% | - | Common Stock | |
| Wolverine World Wide Inc | Jack Boyle | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,459 | 0 | - | - | Restricted Stock Units | |
| Calumet Specialty Products Partners L.P. - Unit | Julio M. Quintana | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 7,067 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Julio M. Quintana | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | Paul C. Raymond | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 31,800 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Paul C. Raymond | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | Karen G. Narwold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 7,067 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Karen G. Narwold | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | Karen A. Twitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | Karen A. Twitchell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 13,389 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Daniel J. Sajkowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | Daniel J. Sajkowski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 84,785 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Amy M. Schumacher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | Amy M. Schumacher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 258,160 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | John G. Boss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 0 | - | - | Restricted Stock Unit | |
| Calumet Specialty Products Partners L.P. - Unit | John G. Boss | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 7,067 | 35,860 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| AMBAC Fin Grp Inc | David Trick | Exec VP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.08 per share. | 09 Jul 2026 | 6,741 | 267,096 (0%) | 0% | 6.1 | 40,985 | Common Stock |
| Planet Labs PBC (Class A) | Carl Bass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 6,479 | 403,665 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Gary B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 6,479 | 38,947 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Kristen O. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 6,479 | 43,586 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Ita M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 6,479 | 259,137 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 6,479 | 256,648 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Scott Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 6,479 | 15,286 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | John W. Raymond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 6,479 | 50,087 | - | 0 | Class A Common Stock | |
| BlackBerry Ltd | Philip S. Kurtz | CLO & Corp. Secretary | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 09 Jul 2026 | 6,414 | 125,158 (0%) | 0% | 11.1 | 71,003 | Common Shares |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share. | 09 Jul 2026 | 6,259 | 265,317 (0%) | 0% | 30.5 | 190,649 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 6,259 | 6,260 | - | - | Stock Option (right to buy) | |
| Block Inc (Class A) | Anthony Eisen | Director | Sale of securities on an exchange or to another person at price $ 76.14 per share. | 09 Jul 2026 | 6,000 | 1,850,672 (0%) | 0% | 76.1 | 456,840 | Class A Common Stock |
| Block Inc (Class A) | Anthony Eisen | Director | Sale of securities on an exchange or to another person at price $ 78.35 per share. | 09 Jul 2026 | 6,000 | 1,838,672 (0%) | 0% | 78.4 | 470,100 | Class A Common Stock |
| Block Inc (Class A) | Anthony Eisen | Director | Sale of securities on an exchange or to another person at price $ 78.91 per share. | 09 Jul 2026 | 6,000 | 1,844,672 (0%) | 0% | 78.9 | 473,460 | Class A Common Stock |
| Ambarella Inc | Yun-Lung Chen | VP, Business Dev. & Marketing | Sale of securities on an exchange or to another person at price $ 78.66 per share. | 09 Jul 2026 | 5,958 | 60,557 (0%) | 0% | 78.7 | 468,656 | Ordinary Shares |
| PTC Therapeutics Inc | Mary Smith | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 09 Jul 2026 | 5,834 | 21,813 (0%) | 0% | 90 | 525,060 | Common Stock |
| PTC Therapeutics Inc | Mary Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.95 per share. | 09 Jul 2026 | 5,834 | 27,647 (0%) | 0% | 42.9 | 250,570 | Common Stock |
| PTC Therapeutics Inc | Mary Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 5,834 | 0 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Ryan Savitz | EVP, CFO & CBO | Sale of securities on an exchange or to another person at price $ 101.97 per share. | 09 Jul 2026 | 5,566 | 0 | - | 102.0 | 567,565 | Common Stock |
| Zoom Video Comm Inc (Class A) | Kimberly J. McGarry | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.40 per share. | 09 Jul 2026 | 5,532 | 7,300 (0%) | 0% | 87.4 | 483,497 | Class A Common Stock |
| Calumet Specialty Products Partners L.P. - Unit | Stephen P. Mawer | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2026 | 5,512 | 311,578 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 116.55 per share. | 09 Jul 2026 | 5,005 | 264,752 (0%) | 0% | 116.6 | 583,333 | Common Stock |
| Hippo Holdings Inc | Rick Mccathron | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.53 per share. | 09 Jul 2026 | 5,000 | 585,433 | - | 28.5 | 142,650 | Common Stock |
| American Outdoor Brands Inc | Brian Daniel Murphy | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 09 Jul 2026 | 4,754 | 387,136 | - | 14.3 | 67,840 | Common Stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 268.73 per share. | 09 Jul 2026 | 4,700 | 2,640 (0%) | 0% | 268.7 | 1,263,023 | Class A Common Stock |
| AMBAC Fin Grp Inc | R. Sharon Smith | Exec VP & Group COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.08 per share. | 09 Jul 2026 | 4,635 | 156,326 (0%) | 0% | 6.1 | 28,181 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 187.17 per share. | 09 Jul 2026 | 4,600 | 8,238,944 (20%) | 0% | 187.2 | 860,982 | Class A common stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 4,440 | 4,440 | - | - | Stock Option (right to buy) | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. | 09 Jul 2026 | 4,440 | 269,757 (0%) | 0% | 17.2 | 76,190 | Common Stock |
| Powell Industries Inc | Brett A. Cope | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 241.55 per share. | 09 Jul 2026 | 4,440 | 517,233 (4%) | 0% | 241.6 | 1,072,482 | Common Stock |
| TruBridge Inc | Andris Upitis | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 4,376 | 0 (0%) | 0% | 26.3 | 114,870 | Common Stock |
| TruBridge Inc | Jerry G. Canada | Director | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 4,376 | 0 (0%) | 0% | 26.3 | 114,870 | Common Stock |
| TruBridge Inc | Merideth Wilson | Financial Health GM | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2026 | 4,308 | 7,734 (0%) | 0% | 0 | Common Stock | |
| TruBridge Inc | David B. Harse | General Manager Patient Care | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2026 | 4,203 | 16,888 (0%) | 0% | 0 | Common Stock | |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 266.98 per share. | 09 Jul 2026 | 4,073 | 15,367 (0%) | 0% | 267.0 | 1,087,418 | Class A Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 09 Jul 2026 | 4,000 | 208,000 | - | 125 | 500,000 | Class A Common Stock |
| Trade Desk Inc (Class A) | Penry W. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 3,602 | 3,602 | - | - | Stock Option (Right to Buy) | |
| Trade Desk Inc (Class A) | Penry W. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 3,602 | 3,602 | - | - | Stock Option (Right to Buy) | |
| Hercules Cap Inc | Seth H. Meyer | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 3,458 | 435,605 (0%) | 0% | 15.7 | 54,256 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 118.52 per share. | 09 Jul 2026 | 3,359 | 259,058 (0%) | 0% | 118.5 | 398,109 | Common Stock |
| BlackBerry Ltd | Jennifer Armstrong-Owen | Sr VP & Chief People Officer | Sale of securities on an exchange or to another person at price $ 10.92 per share. | 09 Jul 2026 | 3,296 | 106,091 (0%) | 0% | 10.9 | 35,992 | Common Shares |
| Sunrun Inc | Maria Barak | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 12.17 per share. | 09 Jul 2026 | 3,278 | 90,033 (0%) | 0% | 12.2 | 39,893 | Common Stock |
| Hercules Cap Inc | Seth H. Meyer | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 3,011 | 439,063 (0%) | 0% | 15.7 | 47,243 | Common Stock |
| Farmers & Merchants Bancorp Inc | Andrew J. Briggs | Director | Sale of securities on an exchange or to another person at price $ 29.42 per share. | 09 Jul 2026 | 3,000 | 132,550 (1%) | 0% | 29.4 | 88,260 | Common Stock |
| Farmers & Merchants Bancorp Inc | Andrew J. Briggs | Director | Sale of securities on an exchange or to another person at price $ 29.52 per share. | 09 Jul 2026 | 3,000 | 129,550 (1%) | 0% | 29.5 | 88,560 | Common Stock |
| Genesco Inc | Gregory A. Sandfort | Director | Purchase of securities on an exchange or from another person at price $ 33.80 per share. | 09 Jul 2026 | 2,958 | 29,172 (0%) | 0% | 33.8 | 99,980 | Common Stock |
| Planet Labs PBC (Class A) | Carl Bass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 2,880 | 406,545 | - | 0 | Class A Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 551.03 per share. | 09 Jul 2026 | 2,863 | 43,722 (0%) | 0% | 551.0 | 1,577,611 | Common Stock |
| Calumet Specialty Products Partners L.P. - Unit | Paul C. Raymond | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2026 | 2,827 | 28,973 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | Daniel J. Sajkowski | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2026 | 2,827 | 81,958 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Calumet Specialty Products Partners L.P. - Unit | John G. Boss | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Jul 2026 | 2,827 | 33,033 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Casey`s General Stores Inc | Ena Williams | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 833.69 per share. | 09 Jul 2026 | 2,800 | 21,969 (0%) | 0% | 833.7 | 2,334,332 | Common Stock |
| Culp Inc | Robert G. Culp | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 09 Jul 2026 | 2,768 | 129,085 (1%) | 0% | 3.3 | 9,217 | Common Stock |
| Planet Labs PBC (Class A) | Ita M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 2,736 | 261,873 | - | 0 | Class A Common Stock | |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 127.44 per share. | 09 Jul 2026 | 2,657 | 352 | - | 127.4 | 338,599 | Class A Common Stock |
| Hallador Energy Co | Daniel Hudson | Director | Purchase of securities on an exchange or from another person at price $ 16.57 per share. | 09 Jul 2026 | 2,500 | 20,000 (0%) | 0% | 16.6 | 41,413 | COMMON STOCK |
| Hallador Energy Co | Daniel Hudson | Director | Purchase of securities on an exchange or from another person at price $ 16.60 per share. | 09 Jul 2026 | 2,500 | 17,500 (0%) | 0% | 16.6 | 41,500 | COMMON STOCK |
| Nelnet Inc (Class A) | James D. Kruger | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2026 | 2,500 | 2,500 (0%) | 0% | 0 | Class A Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 2,464 | 45,036 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.54 per share. | 09 Jul 2026 | 2,464 | 62,763 (0%) | 0% | 46.5 | 114,675 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 90.25 per share. | 09 Jul 2026 | 2,464 | 60,299 (0%) | 0% | 90.3 | 222,376 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 94.33 per share. | 09 Jul 2026 | 2,399 | 110,276 (0%) | 0% | 94.3 | 226,307 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 195.85 per share. | 09 Jul 2026 | 2,389 | 8,248,222 (20%) | 0% | 195.9 | 467,886 | Class A common stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 197.90 per share. | 09 Jul 2026 | 2,358 | 8,243,995 (20%) | 0% | 197.9 | 466,648 | Class A common stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 117.62 per share. | 09 Jul 2026 | 2,335 | 262,417 (0%) | 0% | 117.6 | 274,643 | Common Stock |
| Phoenix Education Partners Inc | Robert Brackenbury | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 2,332 | 2,332 | - | - | Common Stock, par value $0.01 per share | |
| Concrete Pumping Holdings Inc (Class A) | M. Brent Stevens | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.78 per share. | 09 Jul 2026 | 2,300 | 594,855 (1%) | 0% | 10.8 | 24,797 | Common Stock |
| Healthequity Inc | Michael Gathright | Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.07 per share. | 09 Jul 2026 | 2,270 | 39,893 (0%) | 0% | 93.1 | 211,260 | Common Stock |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 09 Jul 2026 | 2,171 | 59,904 | - | 16 | 34,736 | Common Stock |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.30 per share. | 09 Jul 2026 | 2,171 | 57,733 | - | 30.3 | 65,781 | Common Stock |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 2,171 | 15,194 | - | - | Stock Option | |
| Planet Labs PBC (Class A) | Gary B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 2,160 | 41,107 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Scott Reese | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 2,160 | 17,446 | - | 0 | Class A Common Stock | |
| TruBridge Inc | Kevin Plessner | General Counsel | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2026 | 2,150 | 12,460 (0%) | 0% | 0 | Common Stock | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 123.81 per share. | 09 Jul 2026 | 2,111 | 63,493 | - | 123.8 | 261,363 | Class A Common Stock |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 126.48 per share. | 09 Jul 2026 | 2,002 | 3,009 | - | 126.5 | 253,221 | Class A Common Stock |
| EverCommerce Inc | Matthew David Feiersrtein | President | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 09 Jul 2026 | 1,971 | 2,031,679 | - | 10.0 | 19,761 | Common Stock |
| Comstock Holding Co. Inc (Class A) | Robert P. Demchak | Gen. Counsel & Corp Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,969 | 3,936 | - | - | Restricted Stock Units (RSUs) | |
| Comstock Holding Co. Inc (Class A) | Robert P. Demchak | Gen. Counsel & Corp Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,969 | 3,615 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| TruBridge Inc | Vita MacIntyre | Controller | Sale or transfer of securities back to the company at price $ 26.25 per share. | 09 Jul 2026 | 1,934 | 0 (0%) | 0% | 26.3 | 50,768 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 196.82 per share. | 09 Jul 2026 | 1,869 | 8,246,353 (20%) | 0% | 196.8 | 367,857 | Class A common stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 132.07 per share. | 09 Jul 2026 | 1,800 | 209,349 (0%) | 0% | 132.1 | 237,734 | Class A Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 133.12 per share. | 09 Jul 2026 | 1,700 | 207,649 (0%) | 0% | 133.1 | 226,305 | Class A Common Stock |
| Guidewire Software Inc | James Winston King | Chief Admin Officer, Gen Couns | Sale of securities on an exchange or to another person at price $ 130.64 per share. | 09 Jul 2026 | 1,684 | 30,018 (0%) | 0% | 130.6 | 219,998 | Common Stock |
| H.B. Fuller Co | Joao Magalhaes | Sr. VP, Engineering Adhesives | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.10 per share. | 09 Jul 2026 | 1,658 | 5,523 (0%) | 0% | 50.1 | 83,066 | Common Stock |
| H.B. Fuller Co | Joao Magalhaes | Sr. VP, Engineering Adhesives | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,658 | 0 | - | - | Employee Stock Option (Right-to-Buy) | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 552.38 per share. | 09 Jul 2026 | 1,648 | 42,074 (0%) | 0% | 552.4 | 910,323 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 195.04 per share. | 09 Jul 2026 | 1,573 | 8,250,611 (20%) | 0% | 195.0 | 306,798 | Class A common stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 549.01 per share. | 09 Jul 2026 | 1,536 | 48,037 (0%) | 0% | 549.0 | 843,273 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 188.12 per share. | 09 Jul 2026 | 1,504 | 8,237,440 (20%) | 0% | 188.1 | 282,932 | Class A common stock |
| Rhinebeck Bancorp Inc | Kevin Nihill | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.08 per share. | 09 Jul 2026 | 1,468 | 23,696 (0%) | 0% | 17.1 | 25,073 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 550.12 per share. | 09 Jul 2026 | 1,452 | 46,585 (0%) | 0% | 550.1 | 798,780 | Common Stock |
| Hercules Cap Inc | Christian Follmann | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 1,433 | 145,904 (0%) | 0% | 15.7 | 22,484 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 130.63 per share. | 09 Jul 2026 | 1,400 | 211,149 (0%) | 0% | 130.6 | 182,884 | Class A Common Stock |
| Hercules Cap Inc | Christian Follmann | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 1,365 | 144,539 (0%) | 0% | 15.7 | 21,417 | Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,355 | 62,528 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 09 Jul 2026 | 1,355 | 205,354 | - | 125 | 169,375 | Class A Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.78 per share. | 09 Jul 2026 | 1,355 | 210,646 | - | 30.8 | 41,707 | Class A Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,354 | 61,174 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 09 Jul 2026 | 1,354 | 204,000 | - | 125 | 169,250 | Class A Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.78 per share. | 09 Jul 2026 | 1,354 | 212,000 | - | 30.8 | 41,676 | Class A Common Stock |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,310 | 21,884 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Richard Giltner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,310 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Judy D. Olian | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,310 | 5,555 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Judy D. Olian | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,310 | 0 | - | - | Restricted Stock Unit | |
| American Outdoor Brands Inc | H. Andrew Fulmer | EVP, CFO, Treasurer, and Sec. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 09 Jul 2026 | 1,304 | 159,216 | - | 14.3 | 18,608 | Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 1,117 | 63,883 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 09 Jul 2026 | 1,117 | 206,709 | - | 125 | 139,625 | Class A Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.78 per share. | 09 Jul 2026 | 1,117 | 209,291 | - | 30.8 | 34,381 | Class A Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 196.79 per share. | 09 Jul 2026 | 1,111 | 8,233,873 (20%) | 0% | 196.8 | 218,634 | Class A common stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 189.05 per share. | 09 Jul 2026 | 1,056 | 8,236,384 (20%) | 0% | 189.1 | 199,637 | Class A common stock |
| Ally Fin Inc | Thomas P. Gibbons | Director | Grant, award, or other acquisition of securities at price $ 45.95 per share. | 09 Jul 2026 | 1,034 | 26,062 (0%) | 0% | 45.9 | 47,512 | Common Stock |
| Hercules Cap Inc | Kiersten Zaza Botelho | Chief Legal Officer & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 1,018 | 89,388 (0%) | 0% | 15.7 | 15,972 | Common Stock |
| Hercules Cap Inc | Kiersten Zaza Botelho | Chief Legal Officer & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.69 per share. | 09 Jul 2026 | 956 | 90,406 (0%) | 0% | 15.7 | 15,000 | Common Stock |
| American Outdoor Brands Inc | Brent Alan Vulgamott | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 09 Jul 2026 | 903 | 73,241 | - | 14.3 | 12,886 | Common Stock |
| Trade Desk Inc (Class A) | Penry W. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 900 | 900 | - | - | Stock Option (Right to Buy) | |
| Oscar Health Inc (Class A) | Siddhartha Sankaran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 858 | 2,061 | - | - | Deferred Stock Unit | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 553.29 per share. | 09 Jul 2026 | 801 | 41,273 (0%) | 0% | 553.3 | 443,185 | Common Stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 265.66 per share. | 09 Jul 2026 | 800 | 19,440 (0%) | 0% | 265.7 | 212,524 | Class A Common Stock |
| American Outdoor Brands Inc | James E. Tayon | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.27 per share. | 09 Jul 2026 | 795 | 57,810 | - | 14.3 | 11,345 | Common Stock |
| Comstock Holding Co. Inc (Class A) | Robert P. Demchak | Gen. Counsel & Corp Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.72 per share. | 09 Jul 2026 | 794 | 2,821 (0%) | 0% | 15.7 | 12,482 | Class A Common Stock, $0.01 par value |
| Northwestern Corp | Linda G. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 71.62 per share. | 09 Jul 2026 | 768 | 34,586 (0%) | 0% | 71.6 | 55,004 | Common Stock |
| TruBridge Inc | Vita MacIntyre | Controller | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2026 | 753 | 1,934 (0%) | 0% | 0 | Common Stock | |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 189.18 per share. | 09 Jul 2026 | 713 | 17,315,812 (22%) | 0% | 189.2 | 134,883 | Common Stock |
| Ally Fin Inc | David Reilly | Director | Grant, award, or other acquisition of securities at price $ 45.95 per share. | 09 Jul 2026 | 708 | 36,770 (0%) | 0% | 46.0 | 32,533 | Common Stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 269.59 per share. | 09 Jul 2026 | 700 | 1,940 (0%) | 0% | 269.6 | 188,714 | Class A Common Stock |
| Oscar Health Inc (Class A) | William Gassen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 684 | 7,071 | - | - | Deferred Stock Unit | |
| Oscar Health Inc (Class A) | David Alexander Plouffe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 681 | 7,535 | - | - | Deferred Stock Unit | |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 188.55 per share. | 09 Jul 2026 | 680 | 8,252,864 (20%) | 0% | 188.6 | 128,214 | Class A common stock |
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Jan Malcolm | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 775 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Christopher Patusky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Christopher Patusky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 2,140 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 2,983 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Raymond C. Kurzweil | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 13,320 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 5,678 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Nilda Mesa | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 650 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 554.22 per share. | 09 Jul 2026 | 640 | 40,633 (0%) | 0% | 554.2 | 354,704 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 195.82 per share. | 09 Jul 2026 | 640 | 8,234,984 (20%) | 0% | 195.8 | 125,325 | Class A common stock |
| Northwestern Corp | Mahvash Yazdi | Director | Grant, award, or other acquisition of securities at price $ 71.62 per share. | 09 Jul 2026 | 524 | 22,932 (0%) | 0% | 71.6 | 37,529 | Common Stock |
| Northwestern Corp | David L. Goodin | Director | Grant, award, or other acquisition of securities at price $ 71.62 per share. | 09 Jul 2026 | 524 | 5,624 (0%) | 0% | 71.6 | 37,529 | Common Stock |
| Northwestern Corp | Kent T. Larson | Director | Grant, award, or other acquisition of securities at price $ 71.62 per share. | 09 Jul 2026 | 524 | 12,041 (0%) | 0% | 71.6 | 37,529 | Common Stock |
| Northwestern Corp | Britt E. Ide | Director | Grant, award, or other acquisition of securities at price $ 71.62 per share. | 09 Jul 2026 | 524 | 15,558 (0%) | 0% | 71.6 | 37,529 | Common Stock |
| Northwestern Corp | Sherina Maye Edwards | Director | Grant, award, or other acquisition of securities at price $ 71.62 per share. | 09 Jul 2026 | 524 | 9,978 (0%) | 0% | 71.6 | 37,529 | Common Stock |
| Workday (Class A) | David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 134.01 per share. | 09 Jul 2026 | 500 | 207,149 (0%) | 0% | 134.0 | 67,006 | Class A Common Stock |
| Domino's Pizza | Kelly E. Garcia | EVP, Chief Tech & Data Ofcr | Sale of securities on an exchange or to another person at price $ 297.01 per share. | 09 Jul 2026 | 487 | 9,351 (0%) | 0% | 297.0 | 144,644 | Common Stock, $0.01 par value |
| Domino's Pizza | Kelly E. Garcia | EVP, Chief Tech & Data Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 487 | 0 | - | - | Option to Purchase Common Stock | |
| Domino's Pizza | Kelly E. Garcia | EVP, Chief Tech & Data Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 136.89 per share. | 09 Jul 2026 | 487 | 9,838 (0%) | 0% | 136.9 | 66,665 | Common Stock, $0.01 par value |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 198.46 per share. | 09 Jul 2026 | 451 | 8,243,544 (20%) | 0% | 198.5 | 89,505 | Class A common stock |
| 4D Molecular Therapeutics Inc | David Kirn | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.83 per share. | 09 Jul 2026 | 442 | 884,152 | - | 12.8 | 5,673 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 548.16 per share. | 09 Jul 2026 | 440 | 49,573 (0%) | 0% | 548.2 | 241,189 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 193.62 per share. | 09 Jul 2026 | 400 | 8,252,184 (20%) | 0% | 193.6 | 77,448 | Class A common stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 264.48 per share. | 09 Jul 2026 | 400 | 20,240 (0%) | 0% | 264.5 | 105,791 | Class A Common Stock |
| Ameriprise Financial | William F. Truscott | CEO, GLOBAL ASSET MANAGEMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 391 | 5,185 (0%) | 0% | - | Common Stock | |
| Ameriprise Financial | William F. Truscott | CEO, GLOBAL ASSET MANAGEMENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 391 | 639 | - | - | Phantom Stock | |
| Seacoast Banking Corp Of Florida | H. Gilbert Culbreth | Director | Grant, award, or other acquisition of securities at price $ 31.66 per share. | 09 Jul 2026 | 390 | 49,982 (0%) | 0% | 31.7 | 12,347 | Common Stock |
| Billiontoone Inc Ordinary | Oguzhan Atay | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 128.23 per share. | 09 Jul 2026 | 352 | 0 | - | 128.2 | 45,138 | Class A Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 197.49 per share. | 09 Jul 2026 | 329 | 8,233,544 (20%) | 0% | 197.5 | 64,974 | Class A common stock |
| United Therapeutics Corp | Jan Malcolm | Director | Sale of securities on an exchange or to another person at price $ 550.59 per share. | 09 Jul 2026 | 325 | 450 (0%) | 0% | 550.6 | 178,942 | Common Stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 270.49 per share. | 09 Jul 2026 | 300 | 1,640 (0%) | 0% | 270.5 | 81,148 | Class A Common Stock |
| Zoom Video Comm Inc (Class A) | Michelle Chang | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 91.32 per share. | 09 Jul 2026 | 300 | 35,452 (0%) | 0% | 91.3 | 27,395 | Class A Common Stock |
| Arcus Biosciences Inc | Juan Carlos Jaen | President | Sale of securities on an exchange or to another person at price $ 29.40 per share. | 09 Jul 2026 | 268 | 822,240 (1%) | 0% | 29.4 | 7,878 | Common Stock |
| Lowe's | Richard W. Dreiling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 258 | 19,647 | - | - | Phantom Stock | |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 263.62 per share. | 09 Jul 2026 | 238 | 20,640 (0%) | 0% | 263.6 | 62,741 | Class A Common Stock |
| Cross Country Healthcares Inc - Registered Shares | Marvin Veizaga | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.21 per share. | 09 Jul 2026 | 236 | 31,480 (0%) | 0% | 13.2 | 3,118 | Common Stock |
| Ameriprise Financial | Kelli A. Hunter Petruzillo | Exec VP of Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 207 | 4,306 (0%) | 0% | - | Common Stock | |
| Ameriprise Financial | Kelli A. Hunter Petruzillo | Exec VP of Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 207 | 1,109 | - | - | Phantom Stock | |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 191.04 per share. | 09 Jul 2026 | 200 | 8,236,024 (20%) | 0% | 191.0 | 38,208 | Class A common stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 257.20 per share. | 09 Jul 2026 | 200 | 21,240 (0%) | 0% | 257.2 | 51,441 | Class A Common Stock |
| Datadog Inc (Class A) | Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 255.73 per share. | 09 Jul 2026 | 200 | 21,440 (0%) | 0% | 255.7 | 51,146 | Class A Common Stock |
| Ameriprise Financial | William F. Truscott | CEO, GLOBAL ASSET MANAGEMENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 501.94 per share. | 09 Jul 2026 | 180 | 4,794 (0%) | 0% | 501.9 | 90,349 | Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.65 per share. | 09 Jul 2026 | 174 | 208,174 | - | 8.6 | 1,505 | Class A Common Stock |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 174 | 35,826 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | Shan Riku Sakakibara | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 09 Jul 2026 | 174 | 207,826 | - | 125 | 21,750 | Class A Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 193.49 per share. | 09 Jul 2026 | 173 | 8,235,731 (20%) | 0% | 193.5 | 33,474 | Class A common stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 189.18 per share. | 09 Jul 2026 | 164 | 5,171,095 (6%) | 0% | 189.2 | 31,025 | Common Stock |
| Arista Networks | Jayshree V. Ullal | Director, CEO and Chairperson | Sale of securities on an exchange or to another person at price $ 189.18 per share. | 09 Jul 2026 | 164 | 5,171,095 (6%) | 0% | 189.2 | 31,025 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.